Quick Answer
KESTRA MEDICAL TECHNOLOGIES, LTD. reported Long-Term Debt of $41.10 million for fiscal year 2025.
KESTRA MEDICAL TECHNOLOGIES, LTD. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $41.10M | -3.4% |
| 2024 | $42.54M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $42.26M | — | +0.9% |
| October 31, 2025 | $41.87M | — | +0.9% |
| July 31, 2025 | $41.49M | — | +0.9% |
| April 30, 2025 | $41.10M | — | — |
- KESTRA MEDICAL TECHNOLOGIES, LTD. showed a decrease of -3.4% in Long-Term Debt compared to the prior fiscal year.
- Over the 2024–2025 period, KESTRA MEDICAL TECHNOLOGIES, LTD.’s long-term debt has declined by 3.4% (from $42.54 million to $41.10 million).
- The most recent figure is from KESTRA MEDICAL TECHNOLOGIES, LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: